Alexis Sennepin

Alexis Sennepin

Auto-generated profile, based on publicly available information

Alexis Sennepin

Mucosal Entry of HIV and Mucosal Immunity, Institut Cochin, Université de Paris, Paris, France

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
FRFernando Real
Fernando Real
CCClaude Capron
Claude Capron
ASAlexis Sennepin
Alexis Sennepin
RARiccardo Arrigucci
Riccardo Arrigucci
AZAiwei Zhu
Aiwei Zhu
MBMorgane Bomsel
Morgane Bomsel
In addition to hemostasis, human platelets have several immune functions and interact with infectious pathogens including HIV in vitro. Here, we report that platelets from HIV-infected individuals on combined antiretroviral drug therapy (ART) with low blood CD4+ T cell counts (<350 cells/μl) contained replication-competent HIV despite viral suppression. In vitro, human platelets harboring HIV propagated the virus to macrophages, a process that could be prevented with the biologic abciximab, an anti–integrin αIIb/β3 Fab. Furthermore, in our cohort, 88% of HIV-infected individuals on ART with viral suppression and with platelets containing HIV were poor immunological responders with CD4+ T cell counts remaining below <350 cells/μl for more than one year. Our study suggests that platelets may be transient carriers of HIV and may provide an alternative pathway for HIV dissemination in HIV-infected individuals on ART with viral suppression and poor CD4+ T cell recovery.